查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1965468

器官保存液市场－全球产业规模、份额、趋势、机会、预测：按器官类型、应用、区域和竞争格局划分，2021-2031年

Organ Preservation Solution Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Organ Type, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球器官保存解决方案市场预计将从 2025 年的 2.8124 亿美元成长到 2031 年的 4.2006 亿美元，复合年增长率达到 6.92%。

这些解决方案包括专门研发的药物配方，旨在维持细胞活力并减轻器官捐赠至移植期间的缺血性损伤。该市场的成长主要归因于慢性疾病和老化导致的末期器官衰竭发生率不断上升，推动了对移植手术的潜在需求。此外，器官捐赠网络的扩展和长途运输物流系统的加强也促进了这些保存液的持续使用，因为医疗机构致力于提高移植器官的存活率。

市场概览
预测期 2027-2031
市场规模：2025年 2.8124亿美元
市场规模：2031年 4.2006亿美元
复合年增长率：2026-2031年 6.92%
成长最快的细分市场 威斯康辛大学解决方案（UW Solutions）
最大的市场 北美洲

然而，器官需求旺盛而供体数量有限之间的持续缺口，对市场潜力构成重大阻碍。根据全球器官捐赠和移植观察站的数据，截至2024年，全球共进行了172,397例固态器官移植手术。这一数字表明，儘管移植活动持续进行，但可用器官的固有短缺限制了对器官保存解决方案的总需求，从而阻碍了更广泛的市场成长。

市场驱动因素

器官灌注和保存技术的进步正在从根本上改变市场结构，延长捐赠器官的存活时间，并促进边缘捐赠者的利用。目前，器官保存方式正从静态冷冻保存到动态机械灌注系统中发生显着转变，后者可在运输过程中维持器官的代谢活性。这项转变正在改善移植后的预后，并显着扩大癌症后死亡（DCD）捐赠者器官移植的应用范围。这些创新成果的影响已在近期数据中反映出来。根据美国卫生资源与服务管理局（HRSA）于2025年1月发布的《2024年器官捐赠与移植资料》，2024年美国DCD捐赠者数量较去年同期增加23.5%，此成长主要得益于先进的临床保存技术。

同时，全球器官移植手术数量的不断增长是推动保存液消耗量上升的主要因素。随着医疗基础设施的进步和国际捐赠网路效率的提高，需要使用药物保存液的手术总数也增加。根据美国器官移植网络（UNOS）于2025年1月发布的《2024年移植统计数据》，2024年美国共进行了48,149例器官移植手术，较去年同期成长3.3%，增幅显着。儘管手术数量增加，慢性器官衰竭的发生率仍超过器官供应量，凸显了寻找提高移植器官存活率解决方案的必要性。例如，根据英国国家医疗服务体系（NHS）血液和移植组织于2025年11月发布的《英国最新统计数据》，英国仍有8,237名患者在等待器官移植，这更加凸显了有效保存技术的迫切需求。

市场挑战

移植保存液市场商业性规模的主要阻碍因素是供体器官的稀少性。由于这些药物产品是移植过程中器官取得和运输阶段的消耗品，其市场渗透率直接取决于可用移植器官的数量。因此，製造商的获利能力受捐赠者器官供应的限制，而非末期器官衰竭患者的临床需求。所以，一旦器官供应达到饱和，无论疾病流行程度如何，保存液的采购量都将有不可避免的上限。

这种供需失衡造成了持续的瓶颈，限制了整体市场规模。根据器官取得和移植网络（OPTN）的数据，截至2024年1月，美国国家器官移植等待名单上有超过10.3万名候选人。大量等待手术的患者与有限的捐赠器官供应之间存在巨大差距，阻碍了该行业为满足患者需求而进行的扩张。这种失衡导致，儘管挽救生命的手术迫在眉睫，但保存液的销售量仍将受限于每年的交付量。

市场趋势

物联网技术的引入和器官活力即时监测的实现，正在将被动式保存设备转变为以数据为中心的智慧型设备，为市场树立了新的标准。这一趋势着重于透过基于应用程式的生态系统来保护供体器官，该系统持续监测温度和位置等关键参数，从而降低因运输过程中缺乏监控而带来的风险。这项技术的临床益处显着。根据Paragonix Technologies公司于2024年4月发布的「GUARDIAN-Heart临床註册研究」报告，该公司先进的即时监测保存系统与传统的冰冻保存相比，使两年死亡率降低了43%。

同时，体外器官再生疗法和治疗方法的进步正从根本上改变器官保存策略，促进移植器官的主动修復，并显着延长保存期。这些治疗性灌注通讯协定不仅能维持器官功能，还能对关键器官进行功能调整，并提高移植手术安排的柔软性，使手术从紧急手术转向择期手术。例如，XVIVO Perfusion公司在2024年1月的新闻稿（与发表在《采血针》上的一篇论文相关）中宣布，其低温氧合灌注技术已成功将供肝的总保存时间延长至20小时，并在一年内实现了100%的患者和移植器官存活率。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球器官保存解决方案市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依器官类型（心臟、肺、肾臟、肝臟、其他）
    • 依应用方式（静态低温储存、低温机械灌注、常温机械灌注等）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美器官保存解决方案市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲器官保存解决方案市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区器官保存解决方案市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲器官保存解决方案市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲器官保存解决方案市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球器官保存解决方案市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Paragonix Technologies, Inc.
  • XVIVO Perfusion AB
  • Dr. Franz KOhler Chemie GmbH
  • OrganOx Limited
  • Bridge to Life（Europe）Ltd.
  • Waters Medical Systems, LLC
  • Preservation Solutions Inc.
  • Artivion, Inc.
  • Vascular Perfusion Solutions, Inc.
  • Global Transplant Solutions

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 23415

The Global Organ Preservation Solution Market is projected to expand from USD 281.24 Million in 2025 to USD 420.06 Million by 2031, achieving a CAGR of 6.92%. These solutions consist of specialized pharmacological formulations developed to sustain cellular viability and reduce ischemic damage in donor organs during the period between retrieval and transplantation. The market is primarily propelled by the rising incidence of end-stage organ failure caused by chronic illnesses and an aging demographic, which increases the fundamental need for transplant surgeries. Furthermore, the growth of organ donation networks and enhanced logistical systems for long-distance transport bolster the continued use of these preservation media as healthcare providers aim to optimize graft survival outcomes.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 281.24 Million
Market Size 2031USD 420.06 Million
CAGR 2026-20316.92%
Fastest Growing SegmentUniversity of Wisconsin Solution (UW Solution)
Largest MarketNorth America

However, the persistent gap between the high demand for organs and the restricted supply of donors presents a major obstacle to market potential. Data from the Global Observatory on Donation and Transplantation indicates that 172,397 solid organ transplants were conducted worldwide in the year leading up to 2024. This figure highlights that although transplant activity remains strong, the inherent scarcity of viable organs restricts the total volume of preservation solutions required, thereby limiting broader market growth.

Market Driver

Technological progress in organ perfusion and preservation is fundamentally altering the market by prolonging donor organ viability and facilitating the use of marginal grafts. The sector is undergoing a notable shift from static cold storage to dynamic machine perfusion systems, which keep organs metabolically active during transport. This transition enhances post-transplant results and significantly widens the donor pool by rendering organs from Donors After Circulatory Death (DCD) more suitable for transplantation. The effect of these innovations is reflected in recent data; the Health Resources and Services Administration (HRSA), in its '2024 Organ Donation and Transplantation Data' from January 2025, noted a 23.5% increase in DCD donors in the United States in 2024 compared to the prior year, a rise driven by advanced clinical preservation methods.

At the same time, the increasing global volume of transplant procedures acts as a major driver for the consumption of preservation solutions. As healthcare infrastructure advances and international donor networks gain efficiency, the total number of surgeries requiring pharmacological preservation media has grown. According to the United Network for Organ Sharing (UNOS), in its '2024 Annual Transplant Statistics' released in January 2025, the United States reached a milestone with 48,149 transplants in 2024, marking a 3.3% increase over the previous year. Despite this growth in procedure volume, the rate of chronic organ failure continues to exceed organ supply, necessitating solutions that maximize graft survival; for example, NHS Blood and Transplant reported in 'Current UK Statistics' in November 2025 that 8,237 patients remain on the active waiting list in the United Kingdom, emphasizing the critical need for effective preservation.

Market Challenge

The shortage of viable donor organs serves as a primary limitation on the commercial volume of the organ preservation solution market. Because these pharmacological products are consumables used exclusively during the retrieval and transport stages of transplantation, their market uptake is directly tied to the number of available grafts. As a result, revenue potential for manufacturers is constrained by the supply of donor organs rather than the clinical demand from patients with end-stage organ failure. Consequently, when organ availability plateaus, the procurement volume of preservation media faces an unavoidable ceiling, irrespective of disease prevalence.

This imbalance between supply and demand creates a continuing bottleneck that limits the total addressable market. According to the Organ Procurement and Transplantation Network, there were over 103,000 candidates on the national transplant waiting list in the United States as of January 2024. This significant gap between the large number of patients awaiting surgery and the finite inventory of donor organs prevents the industry from scaling in alignment with patient needs. This disparity ensures that, despite the urgent requirement for life-saving procedures, the sales volume for preservation solutions remains confined to the limited number of donations achieved annually.

Market Trends

The adoption of IoT and real-time organ viability monitoring is setting a new benchmark in the market by transforming passive storage units into intelligent, data-centric devices. This trend centers on protecting donor grafts through app-based ecosystems that constantly monitor essential parameters like temperature and location, thereby reducing risks linked to unmonitored transport. The clinical benefit of this technology is significant; a report by Paragonix Technologies in April 2024, regarding the 'GUARDIAN-Heart Clinical Registry', indicated that using their advanced preservation system with real-time monitoring led to a 43% decrease in 2-year mortality rates compared to traditional ice storage.

Simultaneously, progress in ex-vivo organ rehabilitation and therapeutics is fundamentally changing preservation strategies by facilitating active graft repair and significantly extending storage durations. Beyond simple maintenance, these therapeutic perfusion protocols enable the reconditioning of marginal organs and provide greater flexibility in transplant scheduling, shifting procedures from emergency contexts to planned operations. Demonstrating this potential, XVIVO Perfusion announced in a January 2024 press release concerning a 'Lancet' publication that their hypothermic oxygenated perfusion technology successfully prolonged total donor liver preservation time to 20 hours, achieving 100% patient and graft survival at the one-year mark.

Key Market Players

  • Paragonix Technologies, Inc.
  • XVIVO Perfusion AB
  • Dr. Franz KOhler Chemie GmbH
  • OrganOx Limited
  • Bridge to Life (Europe) Ltd.
  • Waters Medical Systems, LLC
  • Preservation Solutions Inc.
  • Artivion, Inc.
  • Vascular Perfusion Solutions, Inc.
  • Global Transplant Solutions

Report Scope

In this report, the Global Organ Preservation Solution Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Organ Preservation Solution Market, By Organ Type

  • Heart
  • Lung
  • Kidney
  • Liver
  • Others

Organ Preservation Solution Market, By Application

  • Static Cold Storage
  • Hypothermic Machine Perfusion
  • Normothermic Machine Perfusion
  • Others

Organ Preservation Solution Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Organ Preservation Solution Market.

Available Customizations:

Global Organ Preservation Solution Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Organ Preservation Solution Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Organ Type (Heart, Lung, Kidney, Liver, Others)
    • 5.2.2. By Application (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Organ Preservation Solution Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Organ Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Organ Preservation Solution Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Organ Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Organ Preservation Solution Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Organ Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Organ Preservation Solution Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Organ Type
        • 6.3.3.2.2. By Application

7. Europe Organ Preservation Solution Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Organ Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Organ Preservation Solution Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Organ Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France Organ Preservation Solution Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Organ Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Organ Preservation Solution Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Organ Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Organ Preservation Solution Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Organ Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Organ Preservation Solution Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Organ Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Organ Preservation Solution Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Organ Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Organ Preservation Solution Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Organ Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Organ Preservation Solution Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Organ Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Organ Preservation Solution Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Organ Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Organ Preservation Solution Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Organ Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Organ Preservation Solution Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Organ Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa Organ Preservation Solution Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Organ Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Organ Preservation Solution Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Organ Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Organ Preservation Solution Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Organ Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Organ Preservation Solution Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Organ Type
        • 9.3.3.2.2. By Application

10. South America Organ Preservation Solution Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Organ Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Organ Preservation Solution Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Organ Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Organ Preservation Solution Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Organ Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Organ Preservation Solution Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Organ Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Organ Preservation Solution Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Paragonix Technologies, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. XVIVO Perfusion AB
  • 15.3. Dr. Franz KOhler Chemie GmbH
  • 15.4. OrganOx Limited
  • 15.5. Bridge to Life (Europe) Ltd.
  • 15.6. Waters Medical Systems, LLC
  • 15.7. Preservation Solutions Inc.
  • 15.8. Artivion, Inc.
  • 15.9. Vascular Perfusion Solutions, Inc.
  • 15.10. Global Transplant Solutions

16. Strategic Recommendations

17. About Us & Disclaimer